CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways

SIMPLE SUMMARY: Some immunotherapies, such as anti-PD1 and anti-PD-L1 treatments, have been used to treat various tumors. However, they are less efficient against esophageal cancer, partially owing to a lack of research on the cellular and molecular mechanisms of this cancer. Therefore, various emer...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xiyang, Yang, Jie, Shi, Anping, Xiong, Yanlu, Wen, Miaomiao, Luo, Zhonglin, Tian, Huanhuan, Zheng, Kaifu, Liu, Yujian, Shu, Chen, Ma, Nan, Wang, Rui, Zhao, Jinbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688614/
https://www.ncbi.nlm.nih.gov/pubmed/36428703
http://dx.doi.org/10.3390/cancers14225610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688614/
https://www.ncbi.nlm.nih.gov/pubmed/36428703
http://dx.doi.org/10.3390/cancers14225610

Ejemplares similares